Abstract
Whole genome analysis has identified rare copy number variations (CNV) that are strongly involved in the pathogenesis of psychiatric disorders, and 3q29 deletion has been found to have the largest effect size. The 3q29 deletion mice model (3q29-del mice) has been established as a good pathological model for schizophrenia based on phenotypic analysis; however, circadian rhythm and sleep, which are also closely related to neuropsychiatric disorders, have not been investigated. In this study, our aims were to reevaluate the pathogenesis of 3q29-del by recreating model mice and analyzing their behavior and to identify novel new insights into the temporal activity and temperature fluctuations of the mouse model using a recently developed small implantable accelerometer chip, Nano-tag. We generated 3q29-del mice using genome editing technology and reevaluated common behavioral phenotypes. We next implanted Nano-tag in the abdominal cavity of mice for continuous measurements of long-time activity and body temperature. Our model mice exhibited weight loss similar to that of other mice reported previously. A general behavioral battery test in the model mice revealed phenotypes similar to those observed in mouse models of schizophrenia, including increased rearing frequency. Intraperitoneal implantation of Nano-tag, a miniature acceleration sensor, resulted in hypersensitive and rapid increases in the activity and body temperature of 3q29-del mice upon switching to lights-off condition. Similar to the 3q29-del mice reported previously, these mice are a promising model animals for schizophrenia. Successive quantitative analysis may provide results that could help in treating sleep disorders closely associated with neuropsychiatric disorders.
Similar content being viewed by others
Introduction
Schizophrenia is a psychiatric disorder that is significantly influenced by genetic factors [1]. However, the pathophysiology leading to the fundamental diagnosis and treatment of this disease remains yet to be elucidated [2, 3]. A major reason for this issue is that although several animal models mimicking human schizophrenia have been developed, no reliable animal model that can be directly used for drug discovery has been established [4,5,6]. Numerous animal models have been developed that mimic genetically validated rare mutants that are believed to be strongly involved in the pathogenesis of psychiatric disorders [7]. Studies show that phenotypic analysis of model mice may help in elucidating the pathophysiology of psychiatric disorders and developing fundamental psychiatric treatment methods [5, 8, 9].
The 3q29 deletion, along with 22q11.2 deletion, is known to be the highest genetic risk factor for schizophrenia, and several patients have been identified in our copy number variation (CNV) analysis [10,11,12]. Individuals with 3q29-del show extremely diverse symptoms, including heart disease, immune disorders, and developmental disorders, as well as symptoms of psychiatric disorders [13]. The human 3q29 region contains 25 genes, for example, Dlg1 and Pak2, and when the amount of these gene products is reduced, various organs become susceptible to loss of function. Patients with 3q29-del have risk factors in all organs of the body, including the brain.
The development of genome editing technology has enabled the creation of mouse models that mimic human CNVs. There are two representative reports published on 3q29-del mice. Rutkowski et al. generated 3q29-del mice and observed behavioral abnormalities such as decreased sociality, spatial learning ability, and memory in male mice [14]. Takemoto et al. and Baba et al. independently generated 3q29-del mice and detected behavioral abnormalities such as increased anxiety-like behavior, decreased sociality, and decreased prepulse inhibition (PPI) [15, 16]. Patients with 22q11.2 deletion present with several individual symptoms, and the phenotypes of 22q11.2 deletion model mice vary not only between different groups of mice but also within a single strain [17, 18]. 3q29 deletion syndrome is another disorder that is characterized by a large individual variation. We have created a new 3q29 deletion mouse model that mimics the 22q11.2 deletion and tested numerous schizophrenia-like behaviors to determine robust phenotypes in this model.
Our 3q29-deficient mouse model also presented with underweight and delayed physical growth, which is consistent with the findings of previous studies [14,15,16]. Moreover, we reevaluated our animal model of schizophrenia by performing a series of general behavioral tests and analyzing the results with those of previous studies. Furthermore, the phenomenon of PV-positive neurons as observed in the mouse model created by Baba et al. was reproduced in the present study [16].
Furthermore, we explored nocturnal activity in this mouse model. Mice are nocturnal animals by nature; however, behavioral analysis is conducted only during the day for human convenience [19], Therefore, to evaluate the activity of mice during the nocturnal activity period, we established a system to measure the activity and body temperature of multiple mice by implanting a small activity sensor, Nano-tag, into their abdominal cavity and acquired data under free-ranging conditions for up to 8 weeks. To date, only a few studies have analyzed this small sensor chip [20, 21]. This chip provides a simple experimental system for understanding whether objective data are related to circadian rhythm abnormalities and sleep disorders, which are believed to be closely associated with psychiatric disorders [22]. Indicators such as activity levels and body temperature can be easily compared between humans and animals and may be worth establishing as a new evaluation method for psychiatric disease models.
Results
Generation of 3q29-del mouse model
To clarify the brain pathology caused by the deletion of the human chromosome 3q29 region, we generated a mouse model of human 3q29-del by genome editing technology. The human chromosome 3q29 region, which contains 25 genes, including BDH1 and TFRC, is equivalent to the mouse chromosome 16B2 region, which also consists of 25 genes, including Bdh1 and Tfrc; we designed mice that lacks this region (Fig. 1a). The CRISPR/Cas9 method was applied to 144 fertilized eggs, and two pups were obtained, one of which was confirmed by polymerase chain reaction (PCR) to possess the deletion allele as designed (Fig. 1b, c). We extracted genomic DNA from the mice and performed whole genome analysis, which confirmed that the CNV deletion existed only in the 16B2 region (Fig. 1d). The offspring from this male mouse were normal (Fig. 1e), and we could detect the deletion mutant allele by PCR (Fig. 1f). Quantification of DLG1 and PAK2 proteins in the 3q29 region using the lysates of fetal brains immediately after birth showed that the expression levels of both genes were half of that of wild-type (WT) brains in the heterozygous deletion (3q29-del) mouse brain (Fig. 1g).
3q29-del have low body weight
We measured body weight changes during the development of 3q29-del mice and performed general behavioral phenotyping after 8 weeks of age. At 3, 4, and 5 weeks of age, the 3q29-del model mice exhibited lower body weight than the WT mice in the same litter (Fig. 2a). Both sexually mature 6-week-old female and 7-week-old male 3q29-del mice also showed lower body weight than WT mice (Fig. 2a). Hematoxylin and eosin staining revealed no significant structural abnormalities in the adult 3q29-del brain (Fig. 2b). The brain weight of 3q29-del mice was also reduced when compared with that of WT mice (Supplementary Fig. 1a–d).
As apoptosis is important for brain development and formation and has been implicated in SCZ [23, 24], immunoblotting was performed using brain samples of 3q29-del mice. Poly(ADP-ribose)polymerase-1 (PARP-1) is a nuclear molecule implicated in various stress responses, and its cleavage by caspase-3 (cPARP) has been shown to enhance apoptosis [25]. We quantified the amount of cPARP in each brain region of the adult WT and 3q29-del mice, indicating that the amount of cPARP was significantly increased only in the hippocampus among the 3q29-del mice compared with the WT mice (p = 0.0476, Mann–Whitney U test) (Fig. 2c, d). Subsequently, we performed TUNEL assays in the hippocampus and cortex of the 3q29-del and WT mice. In the adult hippocampus, apoptosis was increased with an average of 23 signals (N = 5) and 59 signals (N = 5) in 3q29-del per square millimeter, suggesting that apoptosis was also significantly enhanced in the hippocampus of 3q29-del mouse (p = 0.0079) (Fig. 2e). In the adult cortex, TUNEL-positive signals were increased by an average of 12 signals in the WT mice and 18 signals in the 3q29-del mice (p = 0.024) (Fig. 2f). Regarding the visual fields of the hippocampus and cortex at birth, TUNEL-positive signals were significantly increased in the 3q29-del mice than in the WT mice (median of WT mice, 13 (N = 5); median of 3q29-del mice, 19 (N = 5); p = 0. 040) (Fig. 2g). To further investigate the histological pathology, extensive immunostaining was performed on the brain of 3q29 deletion mice using markers for astrocytes, oligodendrocytes, and microglia, but no significant differences were observed in any marker or region (Supplementary Fig. 2a–c).
Histopathological analysis of 3q29-del
The histological comparison of the brains of 3q29-del and WT mice was performed via immunostaining with several neuronal or glial cell markers. In a previous study, the number of parvalbumin (PV)-positive neurons in the cortex of 3q29-del mice was found to be low [16]. Subsequently, we reevaluated the number of PV neurons in the cortex and hippocampus of the reconstituted 3q29-del mice. Moreover, the 3q29-del mice had significantly fewer signals than the WT mice, both in the cortex and hippocampus (hippocampus, p = 0.040; cortex, p = 0.032; Mann–Whitney U test) (Fig. 3). For further histopathological analysis, the distribution of glial cells was also extensively analyzed. The number of signals per square millimeter between the 3q29-del and WT mice were compared via immunostaining with marker antibodies for astrocytes, oligodendrocytes, and microglia compared, but no significant differences were observed in any of the antibodies or regions (Supplementary Fig. 2). Furthermore, the number of signals per square millimeter in the WT and 3q29-del mice were compared via immunostaining with several neuron-specific antibodies, i.e., NeuN, Arc, and TH, but no significant differences were observed in any of the antibodies or regions (Supplementary Fig. 3).
Mouse models of schizophrenia often exhibit reduced neurite outgrowth in in vitro-cultured neurons [26]. We observed in vitro neurite outgrowth of fetal cerebral cortical neurons prepared from 3q29-del mice by time-lapse imaging, but no significant difference was found (Supplementary Fig. 4).
General behavioral analysis of 3q29-del model mice
To clarify the pathophysiological significance of 3q29-del mice in vivo, we conducted a series of general behavioral tests on 3q29-del male mice and their WT male littermates. In the spontaneous locomotion test, in which the number of times a mouse crossed an infrared sensor was counted, the activity of 3q29-del mice was significantly higher than that of WT mice after 2 h of measurement, and the difference was more pronounced in the latter hour (Fig. 4a). In the open field test, the frequency of rearing was significantly higher in 3q29-del mice (Fig. 4b). The novel object recognition test showed that 3q29-del mice were more interested in novel objects than WT mice (Fig. 4c, left). The search time was shorter in 3q29-del mice than in WT mice, suggesting an improvement in learning ability (Fig. 4c, right). The results of other behavioral analyses, such as the Y-maze test performed on male mice, were not significantly different (Supplementary Fig. 5a–g). Behavioral analysis of the same parameters in female mice of a different lot (Supplementary Fig. 6) demonstrated that they spent more time in the inner circle of the open field test, suggesting a decrease in anxiety behavior (Supplementary Fig. 6b). Furthermore, we observed in total exploration time in the retention session of novel object for female mice, suggesting a decrease in search time due to improved learning ability (Supplementary Fig. 6g). The results of the behavioral analysis conducted on male and female mice in this study and a comparison with previously reported results are summarized in Table 1.
3q29-del model mice are hypersensitive to lights on and lights off switching
Among a series of general behavioral tests, the results of the locomotor activity test suggested that 3q29-del mice were hyperactive. Because this test was performed for a short period of time (2 h after a brief acclimation), we measured the activity for a longer period of time (24 h) to account for the diurnal nature of the test. As in the previous locomotor activity tests in behavioral testing, we obtained data for 3q29-del mice and WT mice at 10 weeks of age. The 24-h locomotor activity test was conducted after habituation to 9-h lights, 12-h lights off, and 3-h lights on. Unlike the results of tests completed in 2 h of daytime (Fig. 4a), there was no significant difference in the total amount of activity for each group (Fig. 5a), probably due to the total length of the measurement time. We next plotted the hourly activity volume against time. Data for individual mice are shown in Supplementary Fig. 7. The average value from these time points showed that the increase in activity immediately after lights off was more rapid in 3q29-del mice than in WT mice (Fig. 5b); even for the 15-min interval data, the 3q29-del mice exhibited a significantly faster increase in activity after lights off than the WT mice (Fig. 5c).
Diurnality of long-term activity and body temperature measurements in 3q29-del model mice using Nano-tag
In the 1-day locomotion test in which 3q29-del male mice were kept alone, there was an increase in activity after the change from lights on to lights off, which was more sensitive than that in WT mice. We analyzed this observation more quantitatively in a more natural situation. In general, in the locomotor activity test, the amount of activity is measured by the number of times the mouse crosses the infrared ray in the cage, but long-term measurements were not possible in this study because the animal bedding was not laid. To address this problem, we implanted a small acceleration sensor chip for rodents (product name Nano-tag) in the abdominal cavity of 3q29-del female mice and WT female mice. After implantation, the mice were placed in the same cage for each genotype for a healing period of 1 week. Then the mice were acclimated to the light–dark (L–D) cycle, in which the lights were automatically turned off and on every 12 h, after which measurements were started. The histogram revealed a clear trend of increased activity when the lights were off and decreased activity when the lights were on; hence, we concluded that the measurement system was working well (Fig. 6a–b, Supplementary Fig. 8). We obtained activity and body temperature data from all mice for 6 weeks in the L–D cycle. Similar to the 24-h locomotor activity test, the 3q29-del mice exhibited a significantly faster increase in activity when the lights were off (Fig. 6c, e) and a faster increase in body temperature (Fig. 6d, f) than the WT mice. We also attempted to conduct this experiment with male mice, but it was difficult to obtain stable data due to the high frequency of fights caused by group rearing (data not shown).
Discussion
The 3q29-del mouse model has already been developed and behaviorally analyzed by several research groups, and we performed a comparison of results of these studies, as shown in Table 1 [14,15,16, 27]. In our analysis, we observed an increase in rearing frequency in the open field test, an increase in locomotor activity, and an increase in the novel object recognition test. However, we found no decreases in social interaction or PPI, which is slightly different from previous studies. All mice were generated from the C57BL/6J strain, and the differences in the DNA sequence of the 3q29-del region were minor and well validated. There are also no obvious differences in behavioral phenotypes. Our 3q29-del mice harbored no CNVs other than 16B2 as assessed by whole genome analysis (Fig. 1d). Therefore, we believe that our design of the 3q29 deletion model was quite reasonable. It is possible that delicate behavioral phenotypes are significantly affected by differences in the raising environment and the assessor, and the results may vary. However, the 3q29-del mice were consistent in their phenotype of weight loss [14, 16].
3q29-deficient mice have already been developed and behaviorally analyzed by several research groups including ours as summarized in Table 1 [14,15,16]. Although the behavioral phenotypic comparisons between mouse models are difficult to conduct owing to the differences in the statistical procedures in each study, the results are still different from those of previous studies, with no reduction in social interactions or PPI. In the present study, in the 3q29-del mice, Cas9 protein and guide RNA were microinjected into the fertilized egg pronucleus of the C57BL/6J strain, which was cleaved at two sites with cis, while the cleaved sites were connected and repaired, and the connections were confirmed by sequencing. The 3q29-del mice in the present study harbored no CNVs other than 16B2 as assessed via whole genome analysis (Fig. 1d). In the study of Rutkowski et al., their mouse model was generated by the microinjection of Cas9 mRNA and guide RNA into the fertilized egg pronuclei of the C57BL/6N strain, and the cleavage site by guide RNA was different from ours. In the mouse model of Baba et al., loxP sequences were knocked into the target site by introducing a Cas9 plasmid and guide RNA into the embryonic stem (ES) cells of the C57BL/6J strain, and the recombinant ES cells were injected into the blastocysts through the transient expression of Cre recombinase to produce the chimeric mice. Thus, they do not have completely identical deletions due to the differences in strain and method of generation. Considering this, it can be suggested that the sensitive behavioral phenotype may be greatly affected by the differences in the breeding environment and evaluators, in addition to the differences in the sequences among the mouse models. However, the most objective phenotype of 3q29-deficient mice being underweight is very robust, and either mouse model would be equally valid [14, 16].
This study also evaluated the pathological abnormalities in the brain of 3q29-deficient mice. During apoptosis, the major regions of the brain were most enhanced in the hippocampus and cerebral cortex, and a decrease in the PV neurons as a neuronal cell type was observed, which is consistent with the findings of Baba et al. It can be concluded that the pathological phenotypic abnormalities may also be robust in the brain of 3q29-del mice immediately after birth. The possibility that apoptosis may occur during the developmental period, as apoptosis was found to be enhanced in the brain immediately after birth, should be considered more carefully in terms of susceptible time periods, regions, and cell types.
3q29 deletion is one of the largest risk factors for schizophrenia [28]. In addition to psychiatric symptoms such as schizophrenia, various systemic disorders such as low birth weight or failure to thrive, short stature, ataxia, abnormal skull shape, and heart defects have been reported as characteristics of patients with chromosome 3q29 deletion. Therefore, early diagnosis during the developmental process and long-term follow-up are essential [29,30,31]. In this context, case reports of patients who have been followed up since childhood show that all patients have severe treatment-resistant schizophrenia; and mild-to-moderate learning disabilities, developmental delay, facial dysmorphism, and microcephaly have been observed [29, 30]. In our mouse model mimicking the 3q29 deletion, no phenotype similar to the human case has apparently emerged, which may be affected by the genetic background of the mouse, although this must be investigated in more detail in the future. However, the behavioral phenotype was reconfirmed, strengthening the efficacy of the mouse as a model for schizophrenia. Hence, the possibility of early diagnosis and drug discovery based on the phenotype of these mice has increased.
To achieve this goal, it is important to elucidate the molecular pathogenesis. DLG1 has been identified as a molecule localized in the presynaptic nerve endings of excitatory synapses [32,33,34], and the postmortem brain analysis of patients with schizophrenia showed that DLG1 protein expression in the prefrontal cortex was reduced to less than half of that in controls while the expression of the interacting molecule GluR1 was also reduced [35]. E17.5-day embryos of DLG1 homo-deleted mice exhibited lower body weights than WT mice and mice with heterozygous deletions [36]. PAK2 is a kinase that is activated by Rac1 and Cdc42 of the Rho family and is involved in cytoskeletal remodeling and cell dynamics [37], suggesting an association with ASD [38]. The social behavior of mice with PAK2 heterozygous deletion is reduced and may be related to the social behavior previously observed in 3q29-del mice (Table 1) [38]. For DLG1 and PAK2, we observed that the protein levels were approximately halved in the brain of 3q29-del mice (Fig. 1g). Other genes in the 16B2 region also have vital roles in the brain. For instance, FBXO45 is present at both presynapses and postsynapses, regulates ubiquitin-dependent protein degradation systems, and is involved in synapse function [39]. Moreover, rare variants in Fbxo45 have been identified in patients with schizophrenia, suggesting a link to the disease [40].
In the 3q29-del mice generated by Baba et al., the early gene expressing in neurons, such as c-fos, was elevated in the auditory cortex compared with that in WT mice, indicating increased neural activity [16]. Thus, c-fos mapping of the whole brain of 3q29-del mice may provide clues to elucidate neural circuit pathology; however, it may differ significantly between light and dark phases [41]. In our study, mice in the light phase were obviously less active and hypothermic than those in the dark phase (Fig. 6). We used Nano-tag, a small sensor chip implanted in the body, as a new method to analyze behavioral phenotypes in mouse models of mental illness. The sensor can acquire data on activity and body temperature over a 24-h period for up to 2 months. Currently, the sensor weighs 2 g, which is sufficient for rats [42, 43]. Nevertheless, we cannot deny the fact that this load is quite large compared with the body size of a mouse, which is different from the natural situation. In our analysis, it was difficult to use 8-week-old mice, which are suitable for general behavioral analysis, but only larger, more mature mice aged 5–6 months were used. With more compact sensors, it will be possible to apply the method from a younger stage of mice, and it will also be easier to check and compare with several existing behavioral analyses. With the increasing number of studies using Nano-tag, simultaneous comparisons of activity and temperature data across models of psychiatric disorders could help determine whether the phenotype is unique to the 3q29-del mouse model or is more frequently observed in other models.
There is some information on the interpretation of successive changes in activity and body temperature obtained by introducing Nano-tag into mice. However, we were surprised to find that the diurnal variation of activity was similar to that of the conventional method, in which activity was measured by the number of times the animal crossed the infrared sensor. Furthermore, adding information about body temperature changes has an advantage, and it will be possible to relate it to sleep data. Activity and body temperature data can be obtained by changing the bedding regularly once a week, replenishing food and water, and leaving the rest of the data alone. In addition, the fact that individual identification is possible and that data can be measured in group housing is also a significant advantage in terms of stress reduction. In this study, we used only female mice, so there was almost no noise due to fighting between mice; however, it would be necessary to prevent fighting in male mice. It is known that the rhythms of mice in the dark–dark cycle have a period of every 23.7 h [44], and in our system, we observed that all mice tended to move up the timing from the quiescent to the active phase of their activity. This suggests that the environment was not stressful enough to alter their rhythms (Supplementary Fig. 6). In contrast, in the L–D cycle environment, we observed a significant difference between the two experimental systems, wherein the 3q29-del mice exhibited an earlier transition from quiescence to activity in response to lights off than the WT mice (Fig. 6). The 3q29-del mice may be hypersensitive to light stimuli due to abnormalities in the function of cones and rods, which constitute the retina, or in melanopsin, a photoreceptor [45]. Severe sleep/circadian disruption occurs more frequently in patients with schizophrenia [46]. Additional research on brain regions related to visual pathways is necessary.
Sleep disturbance is a frequently observed medical condition in mental disorders [22, 47]. The accumulation of continuous activity and body temperature data in mouse models of mental disorders, along with the identification of molecular mechanisms and associated neural circuits, may help in investigating sleep disorders, which are closely related to mental disorders [48]. Furthermore, it may be possible to quantitatively evaluate social interactions between mice based on changes in the coordinates of individual mice as they move, although it will be necessary to make significant improvements in the storage capacity and battery capacity of the chip. To verify how this relates to the pathology of patients with 3q29 deletion syndrome, it will be important in the future to match data with patients’ activity and sleep data.
Our newly generated 3q29-del mice, similar to those reported previously, would be a promising animal model for schizophrenia. Activity and body temperature measurements under natural conditions using Nano-tag are simple and could aid in phenotypic analysis that could be easily validated in various neuropsychiatric disease models. Further studies that are focused on rhythm and sleep in 3q29-deficient mice and a better understanding of the molecular pathogenesis of the disease are needed to develop effective therapeutic approaches for sleep disorders that are closely related to neuropsychiatric disorders. Future approaches include transcriptome analysis using the postmortem brains of patients, mice, and patient-derived iPS cells as reported by Sefik et al. to analyze genes within the 3q29 region and phenotypic analysis of as-yet-unknown miRNAs and long non-coding RNAs (lnc RNAs). A phenotypic analysis of genes in the 3q29 region as well as genes deleted from as-yet-unknown miRNAs and long non-coding RNAs (lnc RNAs) should be conducted in consideration of species differences [49].
Materials and methods
Animal experiments
All research and animal care procedures were approved by the Nagoya University Animal Care and Use Committee. Mice were housed in groups of maximum six animals per cage and maintained on a regular 12 h light/dark cycle (9:00–21:00 light period) at a constant 23 °C. Food and water were available ad libitum.
Generating 3q29-del mice by CRISPR/Cas9 system
For the deletion of the region covering the Bdh1 to Tfrc genes of mouse chromosome 16, which corresponds to the human 3q29 region, guide RNAs were designed outside the Bdh1 and Tfrc genes and generated by the CRISPR/Cas9 method. The selection and optimization of the guide RNA was performed according to our previous reports.
For 3q29 deletion model mice production by mycroinjection including Cas9 proteins, 3q29-crRNA and tracrRNA, and donor single-strand DNA (dsDNA) [50,51,52]. Cas9 proteins were purchased from NEB (M0386S, USA). The mixture was injected into pronuclei of one-cell-stage zygotes obtained from C57BL/6J strain (Charles River, USA). The details are described in Supplementary materials.
General behavioral analysis
General behavioral analysis of 3q29-del mice was started with open field test at 8 weeks of age. A series of tests were performed with 11 male WT mice, 11 male 3q29-del mice, 12 WT females, and 12 female 3q29-del mice. The details of the experiments are described in Supplementary materials.
Biological data are expressed as the mean ± SE. Differences between two groups were analyzed by two-tailed Student’s t-test. Differences in locomotor activity, PPI test, fear conditioning test and Rotarod test were analyzed by repeated analysis of variance (ANOVA). Multiple group comparisons were made by one-way ANOVA, followed by Tukey test when F ratios were significant (p < 0.05). The details are described in Supplementary materials.
Measuring activity and body temperature with a small sensor chip, Nano-tag
The Nano-tag (Kissei Comtec Co. Ltd., Nagano, Japan) apparatus measuring spontaneous locomotive activities and body temperature was implanted in the abdominal cavity of mice. The mice were allowed to recover and acclimate to the L–D cycle for 10 days after surgery. Five mice were housed together in one cage; their bedding was changed, and food and water were provided once a week while the lights were turned on. Locomotor activity and body temperature were recorded every 5 min after the start of the measurement for 6 consecutive weeks. These data were analyzed using the Nano-tag Viewer software (Kissei Comtec Co., Ltd.).
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.
References
McGuffin P, Owen MJ, Farmer AE. Genetic basis of schizophrenia. Lancet. 1995;346:678–82.
Insel TR. Rethinking schizophrenia. Nature. 2010;468:187–93.
Zamanpoor M. Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights. Psychiatr Genet. 2020;30:1–9.
Winship IR, Dursun SM, Baker GB, Balista PA, Kandratavicius L, Maia-de-Oliveira JP, et al. An overview of animal models related to schizophrenia. Can J Psychiatry. 2019;64:5–17.
Marcotte ER, Pearson DM, Srivastava LK. Animal models of schizophrenia: a critical review. J Psychiatry Neurosci. 2001;26:395–410.
Wilson C, Terry AV Jr. Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development. Clin Schizophr Relat Psychoses. 2010;4:124–37.
Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148:1223–41.
Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci. 2010;13:1161–9.
Lipska BK, Weinberger DR. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology. 2000;23:223–39.
Kushima I, Aleksic B, Nakatochi M, Shimamura T, Okada T, Uno Y, et al. Comparative analyses of copy-number variation in autism spectrum disorder and schizophrenia reveal etiological overlap and biological insights. Cell Rep. 2018;24:2838–56.
Hiroi N, Takahashi T, Hishimoto A, Izumi T, Boku S, Hiramoto T. Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders. Mol Psychiatry. 2013;18:1153–65.
Mulle JG, Dodd AF, McGrath JA, Wolyniec PS, Mitchell AA, Shetty AC, et al. Microdeletions of 3q29 confer high risk for schizophrenia. Am J Hum Genet. 2010;87:229–36.
Willatt L, Cox J, Barber J, Cabanas ED, Collins A, Donnai D, et al. 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet. 2005;77:154–60.
Rutkowski TP, Purcell RH, Pollak RM, Grewenow SM, Gafford GM, Malone T, et al. Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletion. Mol Psychiatry. 2021;26:772–83.
Takemoto T, Baba M, Yokoyama K, Kitagawa K, Nagayasu K, Ago Y, et al. Correction to: oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndrome. Mol Brain. 2022;15:34.
Baba M, Yokoyama K, Seiriki K, Naka Y, Matsumura K, Kondo M, et al. Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome. Neuropsychopharmacology. 2019;44:2125–35.
Nilsson SR, Fejgin K, Gastambide F, Vogt MA, Kent BA, Nielsen V, et al. Assessing the cognitive translational potential of a mouse model of the 22q11.2 microdeletion syndrome. Cereb Cortex. 2016;26:3991–4003.
Saito R, Miyoshi C, Koebis M, Kushima I, Nakao K, Mori D, et al. Two novel mouse models mimicking minor deletions in 22q11.2 deletion syndrome revealed the contribution of each deleted region to psychiatric disorders. Mol Brain. 2021;14:68.
Yang M, Weber MD, Crawley JN. Light phase testing of social behaviors: not a problem. Front Neurosci. 2008;2:186–91.
Funabashi D, Wakiyama Y, Muto N, Kita I, Nishijima T. Social isolation is a direct determinant of decreased home-cage activity in mice: a within-subjects study using a body-implantable actimeter. Exp Physiol. 2022;107:133–46.
Sakai K, Ishikawa A, Mizuno Y, Maki T, Oda Y, Takahashi E. Simplified drug efficacy screening system for sleep-disorder drugs using non-human primates. Heliyon. 2020;6:e03524.
Kaskie RE, Graziano B, Ferrarelli F. Schizophrenia and sleep disorders: links, risks, and management challenges. Nat Sci Sleep. 2017;9:227–39.
Kristiansen M, Ham J. Programmed cell death during neuronal development: the sympathetic neuron model. Cell Death Differ. 2014;21:1025–35.
Margolis RL, Chuang DM, Post RM. Programmed cell death: implications for neuropsychiatric disorders. Biol Psychiatry. 1994;35:946–56.
Sairanen T, Szepesi R, Karjalainen-Lindsberg ML, Saksi J, Paetau A, Lindsberg PJ. Neuronal caspase-3 and PARP-1 correlate differentially with apoptosis and necrosis in ischemic human stroke. Acta Neuropathol. 2009;118:541–52.
Bellon A. New genes associated with schizophrenia in neurite formation: a review of cell culture experiments. Mol Psychiatry. 2007;12:620–9.
Rutkowski TP, Purcell RH, Pollak RM, Grewenow SM, Gafford GM, Malone T, et al. Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletion. Mol Psychiatry. 2021;26:772–83.
Mulle JG. The 3q29 deletion confers >40-fold increase in risk for schizophrenia. Mol Psychiatry. 2015;20:1028–9.
Harner MK, Lichtenstein M, Farrell M, Dietterich TE, Filmyer DM, Bruno LM, et al. Treatment-resistant psychotic symptoms and early-onset dementia: A case report of the 3q29 deletion syndrome. Schizophr Res. 2020;224:195–7.
Malt EA, Juhasz K, Frengen A, Wangensteen T, Emilsen NM, Hansen B, et al. Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: a case series. Mol Genet Genom Med. 2019;7:e889.
Cox DM, Butler MG. A clinical case report and literature review of the 3q29 microdeletion syndrome. Clin Dysmorphol. 2015;24:89–94.
Chirita Emandi A, Dobrescu AI, Doros G, Hyon C, Miclea D, Popoiu C, et al. A novel 3q29 deletion in association with developmental delay and heart malformation-case report with literature review. Front Pediatr. 2019;7:270.
Sagar A, Bishop JR, Tessman DC, Guter S, Martin CL, Cook EH. Co-occurrence of autism, childhood psychosis, and intellectual disability associated with a de novo 3q29 microdeletion. Am J Med Genet A. 2013;161A:845–9.
Muller BM, Kistner U, Veh RW, Cases-Langhoff C, Becker B, Gundelfinger ED, et al. Molecular characterization and spatial distribution of SAP97, a novel presynaptic protein homologous to SAP90 and the Drosophila discs-large tumor suppressor protein. J Neurosci. 1995;15:2354–66.
Toyooka K, Iritani S, Makifuchi T, Shirakawa O, Kitamura N, Maeda K, et al. Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J Neurochem. 2002;83:797–806.
Naim E, Bernstein A, Bertram JF, Caruana G. Mutagenesis of the epithelial polarity gene, discs large 1, perturbs nephrogenesis in the developing mouse kidney. Kidney Int. 2005;68:955–65.
Bokoch GM. Biology of the p21-activated kinases. Annu Rev Biochem. 2003;72:743–81.
Wang Y, Zeng C, Li J, Zhou Z, Ju X, Xia S, et al. PAK2 haploinsufficiency results in synaptic cytoskeleton impairment and autism-related behavior. Cell Rep. 2018;24:2029–41.
Tada H, Okano HJ, Takagi H, Shibata S, Yao I, Matsumoto M, et al. Fbxo45, a novel ubiquitin ligase, regulates synaptic activity. J Biol Chem. 2010;285:3840–9.
Wang C, Koide T, Kimura H, Kunimoto S, Yoshimi A, Nakamura Y, et al. Novel rare variants in F-box protein 45 (FBXO45) in schizophrenia. Schizophr Res. 2014;157:149–56.
Richetto J, Polesel M, Weber-Stadlbauer U. Effects of light and dark phase testing on the investigation of behavioural paradigms in mice: Relevance for behavioural neuroscience. Pharm Biochem Behav. 2019;178:19–29.
Kaneda Y, Kawata A, Suzuki K, Matsunaga D, Yasumatsu M, Ishiwata T. Comparison of neurotransmitter levels, physiological conditions, and emotional behavior between isolation-housed rats with group-housed rats. Dev Psychobiol. 2021;63:452–60.
Yoshizawa T, Shimada S, Takizawa Y, Makino T, Kanada Y, Ito Y, et al. Continuous measurement of locomotor activity during convalescence and acclimation in group-housed rats. Exp Anim. 2019;68:277–83.
Weber AL. The free-run period is not the best Zeitgeber period for the house mouse. Physiol Behav. 1979;23:1165–9.
Hattar S, Liao HW, Takao M, Berson DM, Yau KW. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science. 2002;295:1065–70.
Wulff K, Dijk DJ, Middleton B, Foster RG, Joyce EM. Sleep and circadian rhythm disruption in schizophrenia. Br J Psychiatry. 2012;200:308–16.
Sanchez Russo R, Gambello MJ, Murphy MM, Aberizk K, Black E, Burrell TL, et al. Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical care. Genet Med. 2021;23:872–80.
Pritchett D, Wulff K, Oliver PL, Bannerman DM, Davies KE, Harrison PJ, et al. Evaluating the links between schizophrenia and sleep and circadian rhythm disruption. J Neural Transm (Vienna). 2012;119:1061–75.
Sefik E, Purcell RH, Emory 3q P, Walker EF, Bassell GJ, Mulle JG. Convergent and distributed effects of the 3q29 deletion on the human neural transcriptome. Transl Psychiatry. 2021;11:357.
Aida T, Chiyo K, Usami T, Ishikubo H, Imahashi R, Wada Y, et al. Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice. Genome Biol. 2015;16:87.
Sawahata M, Mori D, Arioka Y, Kubo H, Kushima I, Kitagawa K, et al. Generation and analysis of novel Reln-deleted mouse model corresponding to exonic Reln deletion in schizophrenia. Psychiatry Clin Neurosci. 2020;74:318–27.
Sekiguchi M, Sobue A, Kushima I, Wang C, Arioka Y, Kato H, et al. ARHGAP10, which encodes Rho GTPase-activating protein 10, is a novel gene for schizophrenia risk. Transl Psychiatry. 2020;10:247.
Tam SKE, Brown LA, Wilson TS, Tir S, Fisk AS, Pothecary CA, et al. Dim light in the evening causes coordinated realignment of circadian rhythms, sleep, and short-term memory. Proc Natl Acad Sci USA. 2021;118:e2101591118.
Acknowledgements
We thank the patients and their families for participating in this study; Division of Experimental Animals and Division for Medical Research Engineering, Nagoya University Graduate School of Medicine for their technical support; the Division of Psychiatry and Brain and Mind Research Center for the help of clinical research; the Center for Advanced Medicine and Clinical Research for the advices of clinical ethics and intellectual properties. Funding for this study was provided by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Ministry of Health, Labor and Welfare of Japan; and AMED under grant No. JP21wm0425007, JP19dm0207075, JP21dk0307103, JP20dk0307099, JP20ek0109488, JP22tm0424222, JP19dm0207069, JP22gm1410011, JP19ak0101126, JP23gm1910005, JP23ek0109678, JP23ak0101215 and JP19ak0101113; and the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant No. 20K20602, 21H04815, 19K07384 and 22K07369. English proofreading of the text was done by Enago Corporation (Japan).
Author information
Authors and Affiliations
Contributions
DM wrote the main text and prepared most of the figures; DM generated the 3q29-del mice; RI and MS performed most of the behavioral and histological experiments; SY, CI, and KK performed nano-tag assay; DM, AK, TH, IK, YA, HO, TS, CM, YH, BA, HK, YN, and HK performed molecular and cellular biological experiments; all other authors commented on and refined the manuscript; NO, KY, KK, KK, TN, TN, and TN supervised the overall project. All authors have carefully read the paper and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mori, D., Ikeda, R., Sawahata, M. et al. Phenotypes for general behavior, activity, and body temperature in 3q29 deletion model mice. Transl Psychiatry 14, 138 (2024). https://doi.org/10.1038/s41398-023-02679-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41398-023-02679-w